Buy Canned medical bile vials 250 ml
  • Buy Canned medical bile vials 250 ml

Bile

Samson-Med OAO
1858 Items
2019-09-19
Dosage form
Brand & Manufacturer
Package Size
$40.56
Quantity
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

Canned medical bile has a local irritant effect.

Indications

Arthralgia; post-traumatic myalgia (without compromising the integrity of the skin).

Composition

1 bottle contains:

Active substance: canned cattle and pig bile;

Excipients: rectified ethyl alcohol, formalin, furatsillina solution in 70% alcohol, perfume

No customer reviews for the moment.

Write your review

Write your review

Bile

Dosage and Administration

Medical bile is used externally. In the form of compresses for 6-10 days.

Gauze napkin (4-6 layers) is plentifully impregnated with the preparation. The napkin is applied to the affected area, covered with waxed paper, a thin layer of cotton and fixed with a light bandage. Holds for a day. When drying, the gauze cloth is moistened with water at room temperature and fixed again with a bandage. A day later, the compresses are replaced with the obligatory new gauze napkin.

Adverse reactions

In rare cases, canned medical bile can cause skin irritation, which quickly disappears when the drug is withdrawn.

In such cases, the subsequent use of compresses is possible only after 30 days.

Contraindications

  • Diagnosed hypersensitivity to the drug. Canned medical bile.
  • Violations of the integrity of the skin in the field of the intended application of the drug.
  • Skin diseases
  • Brand name: Canned medical bile
  • Active ingredient: Bile
  • Dosage form: Emulsion for external use
  • Manufacturer: Samson-Med OAO
  • Country of Origin: Russia

Studies and clinical trials of Bile (Click to expand)

  1. Urinary bile acids and peroxisomal bifunctional enzyme deficiency
  2. How I do it: Thermal bile duct protection during liver cryoablation
  3. Experience with distal bile duct cancers in U.S. Veterans Affairs hospitals: 1987–1991
  4. Synchronous primary tumors of the extrahepatic bile duct and gallbladder
  5. K-ras gene mutations in intrahepatic bile duct tumors of Syrian golden hamsters
  6. Choledochojejunostomy with invagination of the bile duct into the jejunum
  7. Diagnostic and prognostic value of incidence of k-ras codon 12 mutations in resected distal bile duct carcinoma
  8. Aberrations of the K-ras,p53, andAPC genes in extrahepatic bile duct cancer
  9. Prevention of postoperative bile leakage after major hepatic resections in malignancies
  10. Effect of metformin on bile salt circulation and intestinal motility in Type 2 diabetes mellitus
  11. Separatory Determination of Bile Acid 3-Sulfates by Liquid Chromatography/Electrospray Ionization Mass Spectrometry
  12. THREE-DIMENSIONAL RECONSTRUCTION OF PERINEURAL INVASION IN CARCINOMA OF THE EXTRAHEPATIC BILE DUCTS
  13. Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study
  14. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis
  15. Imaging supramolecular aggregates in bile models and human bile
  16. Development and differentiation of bile ducts in the mammalian liver
  17. Development and maintenance of bile canaliculi in vitro and in vivo
  18. Sonographically visible intrahepatic bile ducts in healthy elderly
  19. In vitro sonographic evaluation of common bile duct stones and fragments with a high-frequency microprobe
  20. A study on biliary ductal system and bile fistula in the American alligator,Alligator mississippiensis
  21. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct
  22. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma
  23. Carcinoid tumors of the extrahepatic bile duct : A rare cause of malignant biliary obstruction
  24. Mucin core protein expression in extrahepatic bile duct carcinoma is associated with metastases to the liver and poor prognosis

8 other products in the same category:

arrow_upward